These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 23572046)
21. Molecular characterization of Cyclophilin (TcCyP19) in Trypanosoma cruzi populations susceptible and resistant to benznidazole. Rêgo JV; Duarte AP; Liarte DB; de Carvalho Sousa F; Barreto HM; Bua J; Romanha AJ; Rádis-Baptista G; Murta SM Exp Parasitol; 2015 Jan; 148():73-80. PubMed ID: 25450774 [TBL] [Abstract][Full Text] [Related]
22. Glycoinositolphospholipids, free and as anchors of proteins, in Trypanosoma cruzi. Lederkremer RM; Bertello LE Curr Pharm Des; 2001 Aug; 7(12):1165-79. PubMed ID: 11472260 [TBL] [Abstract][Full Text] [Related]
23. Drug-resistant epimastigotes of Trypanosoma cruzi and persistence of this phenotype after differentiation into amastigotes. Nirdé P; Larroque C; Barnabé C C R Acad Sci III; 1995 Dec; 318(12):1239-44. PubMed ID: 8745639 [TBL] [Abstract][Full Text] [Related]
32. Essential oils from Syzygium aromaticum and Zingiber officinale, administered alone or in combination with benznidazole, reduce the parasite load in mice orally inoculated with Trypanosoma cruzi II. Sarto MPM; Lucas da Silva HF; de Souza Fernandes N; de Abreu AP; Zanusso Junior G; de Ornelas Toledo MJ BMC Complement Med Ther; 2021 Feb; 21(1):77. PubMed ID: 33632196 [TBL] [Abstract][Full Text] [Related]
33. Crystal violet structural analogues identified by in silico drug repositioning present anti-Trypanosoma cruzi activity through inhibition of proline transporter TcAAAP069. Sayé M; Gauna L; Valera-Vera E; Reigada C; Miranda MR; Pereira CA PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007481. PubMed ID: 31961864 [TBL] [Abstract][Full Text] [Related]
34. A quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruzi. Rodrigues JH; Ueda-Nakamura T; Corrêa AG; Sangi DP; Nakamura CV PLoS One; 2014; 9(1):e85706. PubMed ID: 24465654 [TBL] [Abstract][Full Text] [Related]
36. Mapping benznidazole resistance in trypanosomatids and exploring evolutionary histories of nitroreductases and ABCG transporter protein sequences. Petravicius PO; Costa-Martins AG; Silva MN; Reis-Cunha JL; Bartholomeu DC; Teixeira MMG; Zingales B Acta Trop; 2019 Dec; 200():105161. PubMed ID: 31494121 [TBL] [Abstract][Full Text] [Related]
37. Glucose Modulation Induces Lysosome Formation and Increases Lysosomotropic Drug Sequestration via the P-Glycoprotein Drug Transporter. Seebacher NA; Lane DJ; Jansson PJ; Richardson DR J Biol Chem; 2016 Feb; 291(8):3796-820. PubMed ID: 26601947 [TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of cytosolic and mitochondrial tryparedoxin peroxidase in Trypanosoma cruzi populations susceptible and resistant to benznidazole. Nogueira FB; Ruiz JC; Robello C; Romanha AJ; Murta SM Parasitol Res; 2009 Mar; 104(4):835-44. PubMed ID: 19018566 [TBL] [Abstract][Full Text] [Related]
39. Dihydro-beta-agarofuran sesquiterpenes: a new class of reversal agents of the multidrug resistance phenotype mediated by P-glycoprotein in the protozoan parasite Leishmania. Cortés-Selva F; Jiménez IA; Munoz-Martínez F; Campillo M; Bazzocchi IL; Pardo L; Ravelo AG; Castanys S; Gamarro F Curr Pharm Des; 2005; 11(24):3125-39. PubMed ID: 16178749 [TBL] [Abstract][Full Text] [Related]
40. Transcriptomic analysis of benznidazole-resistant and susceptible Trypanosoma cruzi populations. Lima DA; Gonçalves LO; Reis-Cunha JL; Guimarães PAS; Ruiz JC; Liarte DB; Murta SMF Parasit Vectors; 2023 May; 16(1):167. PubMed ID: 37217925 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]